Previous 10 | Next 10 |
2024-02-07 01:53:00 ET Summary A sub-$3trn 2023 for M&A, but new year pipeline gives hope. Rising follow-on equity in 2023 signals latent appetite. Unstoppable debt capital markets hit $8.9trn for FY2023. By Lucille Jones, Senior Manager, Deals Intelligence and...
2024-02-06 03:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-02 03:05:53 ET Summary Leveraged ETFs can experience positive or negative drift depending on the volatility and trend of underlying assets. This article presents a drift dashboard with 22 of them. Direxion Daily S&P 500 Bull 3x Shares ETF has a total return over 30...
2024-01-31 04:36:00 ET Summary 2023 was characterized by narrow leadership and multiple expansions. While last year’s gains have led to headline valuations appearing stretched, there are many segments of the market that are not as aggressively priced. With the expectati...
2024-01-28 01:00:00 ET Summary The U.S. Healthcare sector has shown strong growth and is projected to continue growing due to the increasing number of Americans entering Medicare. The SPDR S&P Biotech ETF invests in biotech and pharmaceutical companies and has a low yield of 0...
2024-01-26 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-25 16:04:05 ET More on iShares MSCI World ETF: URTH: Too Much U.S. Best value ETFs for historical two-month drawdowns in global equities - Barclays Global economic growth set to weaken further this year, World Bank says Seeking Alpha’s Quant Ra...
2024-01-23 18:10:35 ET Summary The SPDR S&P Biotech ETF performance is more dependent on M&A than fundamental growth. The ETF has outperformed the NASDAQ since its inception but has seen a sharp decline since 2021 due to the end of zero-cost capital. The majority of th...
2024-01-17 23:22:58 ET Summary The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to adjust drug prices in line with inflation, provid...
2024-01-16 09:47:08 ET SSgA SPDR Biotech (XBI) XBI is trading DOWN for the last 4 days, and it at trading at $88.79 with volume of 3,434,858 and a one day change of $-1.64 (-1.81%). SSgA SPDR Biotech has a 52-week low of 64.45 and a 52-week high of $92.59. The business's 50-day movi...
News, Short Squeeze, Breakout and More Instantly...
SPDR Series Trust S&P Biotech Company Name:
XBI Stock Symbol:
NYSE Market:
2024-07-08 11:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-18 13:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...